219 related articles for article (PubMed ID: 12455405)
1. Vaccines against polysaccharide antigens.
Lesinski GB; Westerink MA
Curr Drug Targets Infect Disord; 2001 Nov; 1(3):325-34. PubMed ID: 12455405
[TBL] [Abstract][Full Text] [Related]
2. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
Jakobsen H; Jonsdottir I
Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
[TBL] [Abstract][Full Text] [Related]
3. Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.
Adderson EE
Springer Semin Immunopathol; 2001 Dec; 23(4):387-403. PubMed ID: 11826616
[TBL] [Abstract][Full Text] [Related]
4. Novel vaccine strategies to T-independent antigens.
Lesinski GB; Westerink MA
J Microbiol Methods; 2001 Nov; 47(2):135-49. PubMed ID: 11576678
[TBL] [Abstract][Full Text] [Related]
5. [Conjugated vaccines].
Fritzell B
Therapie; 2005; 60(3):249-55. PubMed ID: 16128267
[TBL] [Abstract][Full Text] [Related]
6. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
7. Potential and limitations of polysaccharide vaccines in infancy.
Cadoz M
Vaccine; 1998; 16(14-15):1391-5. PubMed ID: 9711777
[TBL] [Abstract][Full Text] [Related]
8. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.
Michon F; Fusco PC; Minetti CA; Laude-Sharp M; Uitz C; Huang CH; D'Ambra AJ; Moore S; Remeta DP; Heron I; Blake MS
Vaccine; 1998 Nov; 16(18):1732-41. PubMed ID: 9778749
[TBL] [Abstract][Full Text] [Related]
9. Polyosides (encapsulated bacteria).
Lindberg AA
C R Acad Sci III; 1999 Nov; 322(11):925-32. PubMed ID: 10646085
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in bacterial conjugate vaccines.
Goldblatt D
J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
[TBL] [Abstract][Full Text] [Related]
11. The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens.
Mond JJ; Kokai-Kun JF
Curr Top Microbiol Immunol; 2008; 319():17-40. PubMed ID: 18080413
[TBL] [Abstract][Full Text] [Related]
12. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
[TBL] [Abstract][Full Text] [Related]
13. Conjugate vaccines--a breakthrough in vaccine development.
Mäkelä PH
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
Donnelly JJ; Deck RR; Liu MA
J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
[TBL] [Abstract][Full Text] [Related]
15. RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein.
Tang J; Zhang Y; Zhang X; Liao Y; Wang Y; Ouyang S; Che Y; Xu M; Pu J; Shen Q; He Z; Ye Q; Li Q
BMC Immunol; 2018 Jan; 19(1):4. PubMed ID: 29368591
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal vaccines.
Danzig L
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
[TBL] [Abstract][Full Text] [Related]
17. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
18. Modeling the conformations of Neisseria meningitidis serogroup a CPS and a carba-analogue: Implications for vaccine development.
Hlozek J; Ravenscroft N; Kuttel MM
Carbohydr Res; 2019 Dec; 486():107838. PubMed ID: 31654945
[TBL] [Abstract][Full Text] [Related]
19. The promise of conjugate vaccines for Africa.
Kieny MP; LaForce FM
Vaccine; 2007 Sep; 25 Suppl 1():A108-10. PubMed ID: 17548136
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of polysaccharide-specific antibody responses to isolated polysaccharides, conjugate vaccines, and intact Gram-positive versus Gram-negative extracellular bacteria.
Snapper CM
Vaccine; 2016 Jun; 34(30):3542-8. PubMed ID: 27133879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
